2025 Subject Index
PDF
Cite
Share
Request
Index
VOLUME: 3 ISSUE: 4
P: 138 - 138
December 2025

2025 Subject Index

Rheumatol Q 2025;3(4):138-138
No information available.
No information available
PDF
Cite
Share
Request
adalimumab
American College of Rheumatology criteria
anti-Ro antibodies
arthritis
1
autoantibodies
autoimmune hepatitis
Axial spondyloarthritis
60 ,
98 ,
119 ,
Behçet’s disease
1
Behçet’s uveitis
biologic therapies
biological therapy
bone mineral density
Brucella sacroiliitis
CCL4
6
CCR3
6
certolizumab pegol
cervical spine
ChatGPT
chemokine
6
chronic pain
classification criteria
colchicine intoxication
Computed tomography
Connetive tissue disease
corticosteroids
creatine kinase
dizziness
DMARDs
drug survival
early diagnosis
Earthquake
EQIP tool
European Alliance of Associations for Rheumatology criteria
evolution of classification criteria
Familial Mediterranean fever
71 ,
Fibromyalgia
12 ,
6
Flesch-Kincaid Grade Level
Flesch-Kincaid Reading Ease
functional limitation
gastrointestinal tract
genotype
Google trends
Gout
histogram analysis
historical review
history of therapeutic approaches
homozygous
individualized management
1
infliximab
interstitial lung disease
Latent tuberculosis
leflunomide
M694V
MDC
6
medical student
musculoskeletal pain
neurological involvement
1
nintedanib
oesophageal dilatation
ozone therapy
pancreatitis
Paraneoplastic syndrome
phenotype
postmenopausal women
primary biliary cholangitis
prophylaxis
Psoriatic arthritis
pulmonary involvement
quantiferon-plus
radiographic damage
refractory ulcers
refractory uveitis
renal cell carcinoma
rheumatic diseases
Rheumatoid arthritis
40 ,
sacroiliitis
scoliosis
seronegative arthritis
Sjögren’s syndrome
spinal mobility
systemic inflammation
1
systemic sclerosis
20 ,
68 ,
113 ,
tocilizumab
treatment
tumor necrosis factor-alpha inhibitors
tumor necrosis inhibitors
vascular complications
1
zygapophyseal joint